Clinical Trials Directory

Trials / Completed

CompletedNCT03689361

Interest of the T2 * Sequence in MRI for the Diagnosis of Migraine Aura in the Acute Phase.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

investigators hypothesize that T2 \* vein abnormalities are frequent and are specific to the migraine aura.

Detailed description

The diagnosis of migraine aura is now based solely on clinical criteria and the assertion of the diagnosis on these clinical criteria alone proves difficult in the acute phase. Added to this difficulty, the symptomatology of a migraine aura can sometimes be similar to that of a stroke, so a diagnosis can be poorly established, resulting in poor patient care. The possibility of making the positive diagnosis of migraine aura on a routine MRI sequence, T2 \*, would be an important advance for the management of these patients

Conditions

Interventions

TypeNameDescription
COMBINATION_PRODUCTMRIRoutine MRI with all the sequences performed for the management of acute neurological deficit in the Toulouse Neuro Vascular Unit (diffusion, FLAIR, T2 \*, vascular sequences (AngioRM and TOF) and perfusion).
DIAGNOSTIC_TESTMRI controlMRI with all the sequences performed for the management of acute neurological deficit in the Toulouse Neuro Vascular Unit (diffusion, FLAIR, T2 \*, vascular sequences (AngioRM and TOF) and perfusion)
OTHERtelephone consultationtelephone consultation

Timeline

Start date
2018-12-22
Primary completion
2020-10-11
Completion
2020-12-11
First posted
2018-09-28
Last updated
2021-02-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03689361. Inclusion in this directory is not an endorsement.